-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Warren Buffett's State of the Market
Berkshire's cash hoard is approaching "Dr. Evil" levels.
In this podcast, Motley Fool analyst Tim Beyers and host Dylan Lewis discuss:
Americans' options for treating mental health issues could expand soon. MindMed is testing the effects of LSD on depression and anxiety. The company's CEO, Rob Barrow, talks Motley Fool host Ricky Mulvey through his company's work and the future of psychedelics and mental health.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our beginner's guide to investing in stocks. When you're ready to invest, check out this top 10 list of stocks to buy.
